Gene · 3438
Papers2,276
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,276
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Grouper SPL promotes STING- and IRF3-mediated antiviral immune response against iridovirus infection. | Fish Shellfish Immunol | 2025 | 40812757 | PubTator, text mining | PubMed |
| Letter to editor regarding article: expression signatures with specificity for type I and II IFN response and relevance for autoimmune diseases and cancer. | J Transl Med | 2025 | 40804396 | PubTator, text mining | PubMed |
| SUMO operates from a unique long tandem repeat to keep innate immunity in check. | Nucleic Acids Res | 2025 | 40744492 | PubTator, text mining | PubMed |
Immune microenvironment heterogeneity characterizes biologically distinct KRASmut/SPOPmut and KRASmut/PIK3CAmut mesonephric-like adenocarcinoma subtypes revealed by integrated whole-exome and transcriptomic profiling. | Front Immunol | 2025 | 40740763 | PubTator, text mining | PubMed |
| Neural Stem Cell-Derived Extracellular Vesicles for Advanced Neural Repair. | J Neurochem | 2025 | 40734485 | PubTator, text mining | PubMed |
| Age-dependent ACE2/TMPRSS2 expression and SARS-CoV-2 household transmission in Gran Canaria. | PLoS One | 2025 | 40729397 | PubTator, text mining | PubMed |
| Peptide Drug: Design and Clinical Applications. | MedComm (2020) | 2025 | 40717901 | PubTator, text mining | PubMed |
| A tetrazole-based immunomodulator confers mitochondrial protection and enhances host resistance against IHNV in rainbow trout. | Fish Shellfish Immunol | 2025 | 40706912 | PubTator, text mining | PubMed |
| Forty-one Cytokine Profile and Interferon-I Score in Juvenile Dermatomyositis: A Case Series Study. | Recent Adv Inflamm Allergy Drug Discov | 2025 | 40667596 | PubTator, text mining | PubMed |
| Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis. | FEBS J | 2025 | 40621880 | PubTator, text mining | PubMed |
| RBCK1 enhances antiviral response through promoting K63-linked polyubiquitination of IRF7 in Carassius auratus var. Pengze. | Fish Shellfish Immunol | 2025 | 40588086 | PubTator, text mining | PubMed |
| Discovery of Clonixeril as a Sub-Femtomolar Modulator of the Human STING Receptor. | ACS Cent Sci | 2025 | 40585794 | PubTator, text mining | PubMed |
| The puzzling regulation of the interferon signaling system by the p53 tumor suppressor protein. | Cell Mol Life Sci | 2025 | 40512405 | PubTator, text mining | PubMed |
| Andrographolide and Fucoidan Induce a Synergistic Antiviral Response In Vitro Against Infectious Pancreatic Necrosis Virus. | Molecules | 2025 | 40509330 | PubTator, text mining | PubMed |
| Contrasting interferon-mediated antiviral responses in human lung adenocarcinoma cells. | J Virol | 2025 | 40434103 | PubTator, text mining | PubMed |
| IFN-λ: Unleashing Its Potential in Disease Therapies From Acute Inflammation Regulation to Cancer Immunotherapy. | Immunology | 2025 | 40421666 | PubTator, text mining | PubMed |
| Exploring the COVID-19 Vaccine: New Onset and Exacerbations in Rheumatic Diseases. | Cureus | 2025 | 40376360 | PubTator, text mining | PubMed |
| JAK-STAT Signaling in Autoimmunity and Cancer. | Immunotargets Ther | 2025 | 40376194 | PubTator, text mining | PubMed |
| An Integrative Mechanistic Model of Type 1 IFN-Mediated Inflammation in Systemic Lupus Erythematosus. | CPT Pharmacometrics Syst Pharmacol | 2025 | 40364448 | PubTator, text mining | PubMed |
| A focused report on IFN-1 targeted therapies for lupus erythematosus. | Expert Opin Investig Drugs | 2025 | 40047795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3438/papers?page=3